Atai Life Sciences Bets $5 Million on Bitcoin to Survive the Funding Freeze
Atai Life Sciences, a biopharma company listed on NASDAQ, has decided to invest $5 million in Bitcoin BTC.
Skip to content
Live Updates
- XRP ETFs And A Price Surge: What To Expect If The SEC Gives Greenlight
- Cardano Price Surge To $1.7: Here Are The Factors To Drive The Recovery
- Bitcoin Enters New Phase: Analyst Predicts Positive Movement In 2025
- Ethereum Price Eyes $2,000 Breakout Amid Whale Accumulation
- Cardano Developer IOG Seeks $13.4 Million Funding For 2025 Roadmap
Saturday, April 19